Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.
Oncotarget 2015 Nov .
Kushner Brian H, Ostrovnaya Irina, Cheung Irene Y, Kuk Deborah, Modak Shakeel, Kramer Kim, Roberts Stephen S, Basu Ellen M, Yataghene Karima, Cheung Nai-Kong
FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Jun 24 (18): 2885-90.
Cheung Nai-Kong V, Sowers Rebecca, Vickers Andrew J, Cheung Irene Y, Kushner Brian H, Gorlick Richa